Literature DB >> 20180664

The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.

Michelle Tuten1, Sarah H Heil, Kevin E O'Grady, Heather Fitzsimons, Margaret S Chisolm, Hendrée E Jones.   

Abstract

Methadone-maintained pregnant patients with mood disorders have compromised treatment outcomes ( [1] ). This study examined the relationship between the presence of mood disorders and delivery and neonatal outcomes. Participants were categorized into two groups: no current mood disorder (n = 30) or primary mood disorder (n = 38). The mood disorder group reported more serious lifetime and current depression than did the no current mood disorder group. Neonates from mothers with mood disorders had a longer length of stay in the neonatal intensive care unit than the no current mood disorder group. Findings emphasize the need to treat mood disorders in methadone-maintained pregnant patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20180664      PMCID： PMC3057901          DOI： 10.1080/00952990903108231

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN： 0095-2990            Impact factor:   3.829


  22 in total

1.  Psychopathology influences treatment retention among drug-dependent women.

Authors:  Deborah L Haller; Donna R Miles; Kathryn S Dawson
Journal:  J Subst Abuse Treat       Date:  2002-12

2.  Maternal depressive symptoms during pregnancy, and newborn irritability.

Authors:  B Zuckerman; H Bauchner; S Parker; H Cabral
Journal:  J Dev Behav Pediatr       Date:  1990-08       Impact factor: 2.225

3.  Early treatment time course of depressive symptoms in opiate addicts.

Authors:  E C Strain; M L Stitzer; G E Bigelow
Journal:  J Nerv Ment Dis       Date:  1991-04       Impact factor: 2.254

4.  Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women.

Authors:  D S Svikis; J H Lee; N A Haug; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  1997-10-25       Impact factor: 4.492

5.  Perinatal substance abusers. Psychological and social characteristics.

Authors:  D L Haller; J S Knisely; K S Dawson; S H Schnoll
Journal:  J Nerv Ment Dis       Date:  1993-08       Impact factor: 2.254

Review 6.  Treatment issues for opioid-dependent women during the perinatal period.

Authors:  L P Finnegan
Journal:  J Psychoactive Drugs       Date:  1991 Apr-Jun

7.  Posttraumatic stress disorder after pregnancy, labor, and delivery.

Authors:  Marsha M Cohen; Donna Ansara; Berit Schei; Noreen Stuckless; Donna E Stewart
Journal:  J Womens Health (Larchmt)       Date:  2004-04       Impact factor: 2.681

Review 8.  Managing unipolar depression in pregnancy.

Authors:  Julia Raudzus; Shaila Misri
Journal:  Curr Opin Psychiatry       Date:  2009-01       Impact factor: 4.741

9.  Chronic prenatal depression and neonatal outcome.

Authors:  Tiffany Field; Miguel Diego; Maria Hernandez-Reif; Barbara Figueiredo; Saul Schanberg; Cynthia Kuhn; Osvelia Deeds; Jennifer Contogeorgos; Angela Ascencio
Journal:  Int J Neurosci       Date:  2008-01       Impact factor: 2.292

10.  Prenatal depression restricts fetal growth.

Authors:  Miguel A Diego; Tiffany Field; Maria Hernandez-Reif; Saul Schanberg; Cynthia Kuhn; Victor Hugo Gonzalez-Quintero
Journal:  Early Hum Dev       Date:  2008-08-23       Impact factor: 2.079
View more
  16 in total

1.  Clinical correlates of prescription opioid analgesic use in pregnancy.

Authors:  Megan V Smith; Darce Costello; Kimberly A Yonkers
Journal:  Matern Child Health J       Date:  2015-03

2.  Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes.

Authors:  L M Jansson; J A Di Pietro; A Elko; E L Williams; L Milio; M Velez
Journal:  Drug Alcohol Depend       Date:  2011-10-29       Impact factor: 4.492

Review 3.  Opioid Use in Pregnancy.

Authors:  Amalia Londono Tobon; Erin Habecker; Ariadna Forray
Journal:  Curr Psychiatry Rep       Date:  2019-11-16       Impact factor: 5.285

4.  The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.

Authors:  Briana P Patton; Elizabeth E Krans; Joo Yeon Kim; Marian Jarlenski
Journal:  Subst Abus       Date:  2019-03-25       Impact factor: 3.716

5.  Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations.

Authors:  Elizabeth E Krans; Gerald Cochran; Debra L Bogen
Journal:  Clin Obstet Gynecol       Date:  2015-06       Impact factor: 2.190

6.  Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.

Authors:  Margaret M Benningfield; Amelia M Arria; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Gabriele Fischer; Hendrée E Jones; Peter R Martin
Journal:  Am J Addict       Date:  2010 Sep-Oct

Review 7.  Substance Use in the Perinatal Period.

Authors:  Ariadna Forray; Dawn Foster
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

8.  Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.

Authors:  Margaret M Benningfield; Mary S Dietrich; Hendrée E Jones; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Amelia M Arria; Kevin E O'Grady; Gabriele Fischer; Peter R Martin
Journal:  Addiction       Date:  2012-11       Impact factor: 6.526

Review 9.  Substance use in pregnancy: The medical challenge.

Authors:  Kerry-Ann Louw
Journal:  Obstet Med       Date:  2018-03-12

10.  Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment.

Authors:  Diaa M Shakleya; Riet Dams; Robin E Choo; Hendree Jones; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2010 Jan-Feb       Impact factor: 3.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.